Latest news articles

Drug news

Updated results from phase III studies of P 1101 (ropeginterferon alfa-2b) for patients with polycythemia vera- AOP Orphan Pharmaceuticals and PharmaEssentia

AOP Orphan Pharmaceuticals and PharmaEssentia Corporation announced latest results from 3 phase III clinical studies on P 1101 (ropeginterferon alfa-2b)...

Drug news

AWARE real world study of 3,733 chronic urticaria (CU) patients shows inadequate care.

Novartis announced new baseline results from a real world study of 3,733 chronic urticaria (CU) patients showing many are not...

Drug news

FDA approves Symjepi (epinephrine Injection pre-filled single dose syringe) for the emergency treatment of allergic reactions (Type I) including anaphylaxis.-Adamis Pharma

Adamis Pharmaceuticals Corporation announced that the FDA has approved Adamis’ Epinephrine Injection USP, 1:1000 (0.3 mg Pre-filled single dose syringe)...

View all news articles

 

Learning Zones

An epgonline.org Learning Zone (LZ) is an area of the site dedicated to providing detailed self-directed medical education about a disease, condition or procedure.

Allergic Rhinitis

Allergic rhinitis causes great strain on the workforce. Help to reduce sick days and improve productivity with appropriate treatment options.

Visit Allergic Rhinitis


Chronic Spontaneous Urticaria (CSU)

Use our patient case studies to discover how experts diagnose and treat chronic spontaneous urticaria

Visit Chronic Spontaneous Urticaria (CSU)


Hypogonadism

Epidemiology, pathophysiology, diagnosis/treatment guidelines, recent publication summaries and more

Visit Hypogonadism


 

Guidelines

Canadian Guidelines for the Management of Plaque Psoriasis 2009

Since the publication of the 2009 Canadian Guidelines for the Management of Plaque Psoriasis, significant advances have been made in determining the role of T cells in inflammatory and autoimmune diseases. 

British Guideline on the Management of Asthma

Asthma is a common condition which produces a significant workload for general practice, hospital outpatient clinics and inpatient admissions.

Adalimumab for treating moderate to severe hidradenitis suppurativa

Evidence-based recommendations on adalimumab (Humira) for treating active moderate to severe hidradenitis suppurativa in adults whose disease has not responded to conventional systemic therapy.

View all guidelines

Journal articles

Oral Glucocorticoid-Sparing Effect of Benralizumab in Severe Asthma.

Background: Many patients with severe asthma rely on oral glucocorticoids to manage their disease. We investigated whether benralizumab, a monoclonal antibody directed against the alpha subunit of the interleukin-5 receptor...

Japanese guidelines for diagnosis and treatment of urticaria in comparison with other countries.

Several guidelines for urticaria and angioedema have been published in Europe and United States since 1997.

Guidelines for evaluation and management of urticaria in adults and children.

Appropriate management of urticaria depends on the correct evaluation of clinical patterns and causes where these can be identified.

View all journal articles

Clinical trials

Post-Marketing Surveillance of Adalimumab in Korean Hidradenitis Suppurativa Subjects (HS rPMS)

The objective of this study is to evaluate the safety profile of Adalimumab for Hidradenitis Suppurativa (HS) participants in normal medical practice.

Effectiveness of Adalimumab in Moderate to Severe HidrAdenitis SuppuRativa Patients - a Multi cOuNtry studY in Real Life Setting - HARMONY Study

This study will assess the effects of adalimumab treatment in moderate to severe Hidradenitis Suppurativa (HS) patients in the real world setting.

Safety and Efficacy of Humira (Adalimumab) for Hidradenitis Suppurativa (HS) Peri-Surgically (SHARPS Study) (SHARPS)

The objective of this study is to assess the safety and efficacy of adalimumab prior to surgery in subjects with moderate to severe Hidradenitis Suppurativa (HS) who are surgical candidates.

View all clinical trials

Blog Posts

Dr Elizabeth Angier

What’s Allergy got to do with it?

Experiences of an allergy and immunology congress - a short blog (by a primary care physician).

Hugh Harvey

Metrics Madness

You shouldn't judge a book by its cover. That much is true, but it's also common sense not to judge a book by measuring the whiteness of its pages, or the amount of hamsters you can place on it. So why do we measure the fabulous NHS with nonsense metrics?

Edzard Ernst

But he knows nothing about homeopathy!

Whenever I criticise their methods, homeopaths claim that my arguments are invalid because I know next to nothing about the subject. Is this because they feel threatened by my arguments? Or could it be that the allegation is incorrect?

You can judge for yourself - here is a (slightly shortened and revised) excerpt from my recent memoire ‘A SCIENTIST IN WONDERLAND’ which recounts my exposure to and experience in homeopathy.

CME

Ask an expert: Psoriasis

Accrediting body
BMJ Learning - British Medical Learning
Credits available
1
Registration required
1
Subscription fee
90

Chronic Spontaneous Urticaria Case Consults: Changing Paradigms in the Age of Biologics

Chronic Spontaneous Urticaria Case Consults: Changing Paradigms in the Age of Biologics
Accrediting body
Union of European Medical Specialists (via European Accreditation Council for CME)
Credits available
1
Registration required
1
Subscription fee
FREE

Management of hidradenitis suppurativa

Accrediting body
BMJ Learning - British Medical Learning
Credits available
1
Registration required
1
Subscription fee
90
View all CME